Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab

Developments in the understanding of the immunopathogenesis of psoriasis have identified interleukin (IL)-17 as the key proinflammatory cytokine in the pathogenesis of plaque psoriasis, with the consequent development of drugs that target this cytokine or associated receptors. Ixekizumab is a subcut...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanley, Tessa L, Yiu, Zenas ZN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358983/
https://www.ncbi.nlm.nih.gov/pubmed/28352182
http://dx.doi.org/10.2147/TCRM.S111107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358983/
https://www.ncbi.nlm.nih.gov/pubmed/28352182
http://dx.doi.org/10.2147/TCRM.S111107

Ejemplares similares